BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14708511)

  • 1. K-ras as a genetic marker in pancreatic cancer.
    Nakayama T; Morishita T; Kamiya T
    Acta Gastroenterol Latinoam; 2003; 33(1):43-6. PubMed ID: 14708511
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of the Ki-ras mutation as a specific and sensitive marker of pancreatic carcinoma].
    Krechler T; Janda J; Dufek V; Kaláb M; Pesková M; Dorazilová V
    Vnitr Lek; 1997 Oct; 43(10):678-81. PubMed ID: 9601883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of K-ras point mutation at codon 12 in pancreatic diseases: a study in a Brazilian casuistic.
    Kubrusly MS; Cunha JE; Bacchella T; Abdo EE; Jukemura J; Penteado S; Morioka CY; de Souza LJ; Machado MC
    JOP; 2002 Sep; 3(5):144-51. PubMed ID: 12221329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of K-ras gene mutation at codon 12 by pancreatic duct brushing for pancreatic cancer.
    Liu F; Li ZS; Xu GM; Sun ZX; Zhou GX; Ren XX; Tu ZX; Gong YF
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):313-7. PubMed ID: 14599992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.
    Arvanitakis M; Van Laethem JL; Parma J; De Maertelaer V; Delhaye M; Devière J
    Endoscopy; 2004 Jun; 36(6):535-42. PubMed ID: 15202051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of chronic pancreatitis patients with K-ras mutation in the pancreatic juice.
    Kamisawa T; Takuma K; Tabata T; Egawa N; Yamaguchi T
    Hepatogastroenterology; 2011; 58(105):174-6. PubMed ID: 21510309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic diagnosis of pancreatic cancer.
    Mizumoto K; Tanaka M
    J Hepatobiliary Pancreat Surg; 2002; 9(1):39-44. PubMed ID: 12021896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of small pancreatic cancer diagnosed by serial follow-up studies promptly by a positive K-ras point mutation in pure pancreatic juice.
    Ochi K; Hasuoka H; Mizushima T; Matsumura N; Harada H
    Am J Gastroenterol; 1998 Aug; 93(8):1366-8. PubMed ID: 9707068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular diagnosis in pancreatic carcinoma].
    Dítĕ P; Lukás Z; Hermanová M; Kroupová I; Kleibl Z; Brázdil J; Pazourková M; Novotný Z; Růzicka M
    Vnitr Lek; 2003 Jul; 49(7):559-62. PubMed ID: 12931440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
    Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S
    Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis.
    Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
    Int J Gastrointest Cancer; 2005; 35(1):33-41. PubMed ID: 15722572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-ras mutations and the diagnosis of pancreatic carcinoma.
    Robinson RA
    Am J Clin Pathol; 1996 Mar; 105(3):257-9. PubMed ID: 8602603
    [No Abstract]   [Full Text] [Related]  

  • 14. An unfavourable prognosis for pancreatic cancer indicates fields of opportunity.
    Greenhalf W
    Gut; 2006 Nov; 55(11):1533-5. PubMed ID: 17047104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations.
    Midwinter MJ
    Br J Surg; 1998 Jul; 85(7):1015. PubMed ID: 9692590
    [No Abstract]   [Full Text] [Related]  

  • 16. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of pancreatic adenocarcinoma with novel K-ras mutation and long term survival.
    Toyooka S; Tsukuda K; Mizuta M; Soh J; Shirakawa K; Shimizu K; Shimizu N
    Am J Gastroenterol; 2002 Jul; 97(7):1852-3. PubMed ID: 12135058
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution.
    Soliman AS; Lo AC; Banerjee M; El-Ghawalby N; Khaled HM; Bayoumi S; Seifeldin IA; Abdel-Aziz A; Abbruzzese JL; Greenson JK; Hamilton SR
    Carcinogenesis; 2007 Aug; 28(8):1794-9. PubMed ID: 17575320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis.
    Wenger FA; Zieren J; Peter FJ; Jacobi CA; Müller JM
    Langenbecks Arch Surg; 1999 Apr; 384(2):181-6. PubMed ID: 10328172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Ki-ras oncogene mutations in pancreatic diseases: helpful or irrelevant?
    Van Laethem JL
    Acta Gastroenterol Belg; 1998; 61(3):295-7. PubMed ID: 9795456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.